The week in health tech, explained in plain English.Get the free newsletter →
November 18, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

VA-Oracle Health EHR Contract Ceiling Jumps to $26.9B

The U.S. Department of Veterans Affairs has raised the ceiling on its Oracle Health electronic health record contract to $26.9 billion, according to an award notice published Aug. 19 on SAM.gov and reported by Becker's Hospital Review. The VA awarded the $16.9 billion modification on Aug. 18, stacking it on top of the deal's original $9.99 billion ceiling.

The expanded ceiling caps a program that has been one of the most scrutinized federal IT efforts in years. The VA originally signed with Cerner, now part of Oracle, in 2018 to replace its homegrown VistA system. The rollout was paused in 2023 after patient safety concerns and outages at early sites before the agency moved to restart and broaden deployments.

A higher ceiling is not new spending by itself, but it signals the VA expects to pay far more as it pushes the system across its hospital network. For Oracle, it locks in one of the largest health IT commitments in government, with billions still riding on whether the restarted deployments go smoothly.

More in Government

Government

US Loses Measles Elimination Status After a Year of Spread

Global health authorities say the US has lost its measles elimination status after the disease spread continuously for over a year, ending a 25-year milestone.

Why it matters: Losing measles elimination status signals that a highly contagious, vaccine-preventable disease is again circulating freely in the U.S., threatening public health gains.

Government

Mark Cuban's Cost Plus to Develop US-Made Ibogaine for HHS

Mark Cuban Cost Plus Drug Co. will lead HHS-backed research to develop a US-made ibogaine product for PTSD and other mental illnesses, supported by up to $4.9 million.

Why it matters: Federal funding for domestically made ibogaine signals rising government interest in psychedelics for hard-to-treat conditions like PTSD in veterans.